- 2024-08-20 02:02抑制剂Methylproamine|Methylproamine|188247-01-0|Adamas life|≥98%（以实测数值为准）|BR|500mg
- 2024-08-20 02:02抑制剂MF-438|MF-438|921605-87-0|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 02:02抑制剂MG-262|MG-262|179324-22-2|Adamas life|≥98%（以实测数值为准）|BR|1mg
- 2024-08-20 02:02抑制剂MG-262|MG-262|179324-22-2|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 02:02抑制剂Methoxy-X04|Methoxy-X04|863918-78-9|Adamas life|≥98%（以实测数值为准）|BR|100mg
- 2024-08-20 02:02抑制剂Methylproamine|Methylproamine|188247-01-0|Adamas life|≥98%（以实测数值为准）|BR|100mg
- 2024-08-20 02:02抑制剂Methylproamine|Methylproamine|188247-01-0|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 02:02抑制剂Metarrestin|Metarrestin|1443414-10-5|Adamas life|≥98%（以实测数值为准）|BR|1mg
- 2024-08-20 02:02抑制剂Metarrestin|Metarrestin|1443414-10-5|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 02:02抑制剂Metarrestin|Metarrestin|1443414-10-5|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 02:02抑制剂Methotrexate metabolite|Methotrexate metabolite|19741-14-1|Adamas life|≥98%（以实测数值为准）|BR|100mg
- 2024-08-20 02:02抑制剂Mesdopetam hemitartrate|Mesdopetam hemitartrate|2562346-14-7|Adamas life|≥98%（以实测数值为准）|BR|1mg
- 2024-08-20 02:02抑制剂Mesdopetam hemitartrate|Mesdopetam hemitartrate|2562346-14-7|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 02:02抑制剂Mesdopetam hemitartrate|Mesdopetam hemitartrate|2562346-14-7|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 02:02抑制剂MeBIO|MeBIO|667463-95-8|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 02:02抑制剂Mecillinam|Mecillinam|32887-01-7|Adamas life|≥98%（以实测数值为准）|BR|100mg
- 2024-08-20 02:02抑制剂Mecillinam|Mecillinam|32887-01-7|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 02:02抑制剂Mecillinam|Mecillinam|32887-01-7|Adamas life|≥98%（以实测数值为准）|BR|500mg
- 2024-08-20 02:02抑制剂MDL-28170|MDL-28170|88191-84-8|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 02:02抑制剂MeBIO|MeBIO|667463-95-8|Adamas life|≥98%（以实测数值为准）|BR|1mg
